Olalekan Oluwole MBBS, MPH

Olalekan Oluwole, MBBS, MPH, is Assistant Professor of Medicine in the Department of Hematology/Oncology at Vanderbilt-Ingram Cancer Center. He also is a faculty member of the Vanderbilt Institute for Infection, Immunology, and Inflammation.

Dr. Oluwole received his medical degree from University of Ibadan in Nigeria and a Master of Public Health degree at the University of Medicine and Dentistry of New Jersey. He completed his post-graduate training with a residency in laboratory medicine at University College Hospital, an internal medicine residency at the Morehouse School of Medicine, and a hematology/oncology fellowship at Vanderbilt University.

Dr. Oluwole specializes in the treatment of malignant hematologic disorders with a research focus on chronic lymphocytic leukemia, Hodgkin lymphoma, and non-Hodgkin lymphomas. He is engaged in clinical trials using targeted therapies aimed at improving treatment outcomes in patients with hematologic malignancies. He also serves as a portfolio coach at Vanderbilt University School of Medicine, where he guides individual medical students in developing the skills for informed self-assessment and life-long learning.

Dr. Oluwole has authored or co-authored research articles in peer-reviewed journals and written a book chapter. He is a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and American College of Physicians (ACP).

Dr. Oluwole serves as a member of the NCCN Acute Lymphoblastic Leukemia Panel and the NCCN Management of Immunotherapy-Related Toxicity Panel.